Product specific guidance EMA [BE/BA News]

posted by Mahesh M – India, 2015-10-07 11:51 (3117 d 10:16 ago) – Posting: # 15523
Views: 6,935

Dear All,

EMA release Product specific guidance for below product

Scientific guideline: Draft ticagrelor film-coated tablets 90mg product-specific bioequivalence guidance, draft: consultation open

Scientific guideline: Draft rivaroxaban film-coated tablets 2.5, 10, 15 and 20mg product-specific bioequivalence guidance, draft: consultation open

Scientific guideline: Draft lenalidomide hard gelatine capsules 2.5, 5, 7.5, 10, 15 and 25mg product-specific bioequivalence guidance, draft: consultation open

Scientific guideline: Draft entecavir film-coated tablets 0.5 and 1 mg, oral solution 0.05mg/ml product-specific bioequivalence guidance, draft: consultation open

Scientific guideline: Draft entecavir film-coated tablets 0.5 and 1 mg, oral solution 0.05mg/ml product-specific bioequivalence guidance, draft: consultation open

Regards
M


Edit: Category changed. All product-specific guidances published so far: List. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,661 registered users;
107 visitors (0 registered, 107 guests [including 5 identified bots]).
Forum time: 22:07 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5